Li et al. showed that the HDAC inhibitor valproic acid (Depakene) leads to increased acetylation of the PTEN promoter which in turn inhibits PI3K/AKT signalling and proliferation in Raji and CA46 BL cell lines [87]. The gene discussed is HDAC9; the disease is Burkitt lymphoma.